Breast cancer remains the most commonly diagnosed cancer among women and a leading cause of cancer-related death. Each October, Breast Cancer Awareness Month serves as a reminder of the importance of early detection, timely treatment, and equitable access to care. For clinicians and public health professionals, the latest data and trends offer critical insight into how breast cancer affects communities, where disparities persist, and which strategies can make the greatest impact. This resource brings together key facts to support awareness efforts and guide evidence-based action.

September is Childhood Cancer Awareness Month, a time to recognize the impact of cancer as the leading cause of disease-related death among children in the United States. For clinicians and public health professionals, understanding the latest data on incidence, survival, and disparities is key to advancing early detection, treatment, and supportive care. The following resources provide current statistics and evidence-based tools to guide clinical decision-making and inform community health strategies.

Gynecological cancers—including cervical, ovarian, uterine, vaginal and vulvar cancers—represent a significant burden on women’s health, with incidence and outcomes varying across populations. For clinicians and public health professionals, access to timely data and evidence-based resources is critical to improving prevention, early detection and treatment. The following information provides an overview of current trends and tools to support patient care and community health strategies.

Prostate cancer is the most commonly diagnosed cancer among men in Nevada (excluding skin cancer) and the second leading cause of cancer death for men in the state, behind lung cancer. Below you'll find resources and data to assist you in discussing prostate cancer and sharing the latest information.

On Monday, August 25, the first day of the fall semester, Nevada State University joined more than 2,100 colleges and universities nationwide—including the University of Nevada, Las Vegas and the University of Nevada, Reno—that have adopted 100% tobacco-free campus policies. 

Colorectal cancer has long been considered a disease of older adults. But new research shows that younger generations are facing a very different reality.

New cancer therapies are saving lives—but they are also leaving lasting financial scars.

A new study in the Journal of the National Cancer Institute sheds light on the complex reality patients face when innovative treatments reach the market. Researchers examined advanced non-small cell lung cancer, a disease where new therapies have shown promise.

Six individuals and one organization were honored Wednesday, Aug. 27 by the Nevada Cancer Coalition for their dedidcation to reducing the burden of cancer for Nevadans. The individuals received Summit Awards during an awards luncheon as part of the annual Nevada Cancer Control Summit, a statewide conference for healthcare and public health professionals held at the Carpenter International Training Center.

Per- and polyfluoroalkyl substances (PFAS) are a large class of human-made chemicals that have been used since the 1940s in countless consumer and industrial products due to their resistance to heat, water, and oil. While these qualities make PFAS useful, they also make them persistent environmental contaminants. PFAS do not break down in the environment, accumulate in soil and water, and have been linked to numerous health effects, including risks to immune, reproductive, and developmental health and increased risk of some cancers.